-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80

Benzinga·11/20/2026 13:32:52
Listen to the news
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $70 to $80.